0.6580
-0.0220
(-3.19%)
As of 2:58:34 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ATLAS VENTURE FUND XI L.P Beneficial Owner of more than 10% of a Class of Security | Sale | Feb 8, 2024 | -- |
| BRENNAN KEVIN M Officer | Sale | Jan 2, 2025 | 3,197 |
| FRANKENFIELD CHRISTOPHER JAMES Chief Financial Officer | Sale | Jan 2, 2025 | 12,421 |
| GILEAD SCIENCES INC Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 18, 2024 | 9,105,450 |
| LUPTAKOVA KATARINA M.D. Officer | Conversion of Exercise of derivative security | Dec 31, 2024 | 16,625 |
| RUSSO RENE PHARM.D. Chief Executive Officer | Conversion of Exercise of derivative security | Dec 31, 2024 | 244,883 |
Related Tickers
INAB IN8bio, Inc.
0.1481
-3.01%
SNSE Sensei Biotherapeutics, Inc.
0.3053
-2.46%
MRSN Mersana Therapeutics, Inc.
0.2788
-8.17%
IOBT IO Biotech, Inc.
0.8537
-2.77%
CTMX CytomX Therapeutics, Inc.
0.5038
+0.70%
IMRX Immuneering Corporation
1.2200
-5.43%
RLYB Rallybio Corporation
0.2527
+1.08%
KTTA Pasithea Therapeutics Corp.
1.5700
+45.37%
SPRC SciSparc Ltd.
0.2700
-2.00%
ALXO ALX Oncology Holdings Inc.
0.4792
-7.62%